The Gynecological Cancers Research Program at the Center for Women’s Health and Reproductive Medicine at the University of Pennsylvania is dedicated to advancing the understanding, prevention, and treatment of cancers that affect the female reproductive system. Our research encompasses various gynecologic cancers, including ovarian, cervical, uterine, vaginal, and vulvar cancers. Through cutting-edge research and innovative clinical trials, our team aims to uncover the underlying mechanisms of these cancers, identify new biomarkers for early detection, and develop more effective, personalized treatment strategies.

Our multidisciplinary team of experts collaborates closely with oncologists, surgeons, pathologists, and geneticists to ensure a comprehensive approach to gynecologic cancer research. By leveraging advanced technologies such as genomic sequencing, immunotherapy, and targeted therapies, we strive to improve patient outcomes and quality of life. Our research also focuses on understanding the genetic and environmental risk factors associated with gynecologic cancers, aiming to develop preventive measures that can reduce the incidence of these diseases.

In addition to our laboratory and clinical research efforts, we are committed to translating our findings into tangible benefits for patients. Our clinical trials provide patients with access to the latest treatment options and innovative therapies, often before they are widely available. We also prioritize patient education and support, offering resources and guidance to help patients and their families navigate the complexities of cancer treatment and care.

Through our relentless pursuit of knowledge and our dedication to improving women’s health, the Gynecological Cancers Research Program at the Center for Women’s Health and Reproductive Medicine continues to make significant strides in the fight against gynecologic cancers. Our ultimate goal is to reduce the burden of these cancers and enhance the lives of women affected by them, both now and in the future.

Related News

Dr. Kristin Gerson, MD Ph.D. appointed to Jerome F. Strauss III, MD Ph.D. Assistant Professorship of Obstetrics and Gynecology

Congratulations to Dr. Kristin Gerson, MD Ph.D. on her appointment to the Jerome F. Strauss III, MD Ph.D. Assistant Professorship of Obstetrics and Gynecology. Appointment to an endowed professorship is … Continue reading Dr. Kristin Gerson, MD Ph.D. appointed to Jerome F. Strauss III, MD Ph.D. Assistant Professorship of Obstetrics and Gynecology

Penn Medicine’s Samuel Parry, MD, awarded 2026 Society of Maternal Fetal Medicine Lifetime Achievement Award

Congratulations to Dr. Sam Parry, the Franklin Payne Professor of Obstetrics and Gynecology and CWHRM member on receiving the 2026 Society of Maternal Fetal Medicine Lifetime Achievement award! Dr. Parry … Continue reading Penn Medicine’s Samuel Parry, MD, awarded 2026 Society of Maternal Fetal Medicine Lifetime Achievement Award

How Dad’s Fitness May Be Packaged and Passed Down in Sperm RNA

Colin Conine is featured in a recent article of Quanta Magazine. How Dad’s Fitness May Be Packaged and Passed Down in Sperm RNA

Register for the 2026 CWHRM Symposium!

Registration is now open for the 2026 CWHRM Symposium which will take place on Monday March 2, 2026 in Smilow Commons and Rubenstein Auditorium. The Cuozzo keynote lecture will be … Continue reading Register for the 2026 CWHRM Symposium!

Cardiac Grants Propel Cutting-Edge Research to Transform Outcomes for Children with Severe Heart Conditions

The collaborative efforts, led by researchers at Children’s Hospital of Philadelphia, aim to advance cardiac care treatment paradigms. J. William Gaynor, MD, a surgeon in the Cardiac Center at CHOP, is … Continue reading Cardiac Grants Propel Cutting-Edge Research to Transform Outcomes for Children with Severe Heart Conditions

New research seeks an mRNA therapy for heavy menstrual bleeding

Every minute in the U.S., a woman requires a blood transfusion because of her period. “Heavy menstrual bleeding affects one in three women, but our resources for treating it are … Continue reading New research seeks an mRNA therapy for heavy menstrual bleeding

Save the Date – Tri-Repro 2026

  Mark your calendars, Tri-Repro 2026 will take place April 30-May 1 at Cornell University in Ithaca, NY. Registration will open in early 2026, so be sure to check back … Continue reading Save the Date – Tri-Repro 2026

A Penn Medicine Nurse Who Donated Her Uterus Helps Another Family’s Dream Come True

Of the more than six million women in the United States who struggle with infertility, approximately 100,000 have uterine factor infertility (UFI), a condition characterized by the absence of a … Continue reading A Penn Medicine Nurse Who Donated Her Uterus Helps Another Family’s Dream Come True

Kotaro Sasaki and his team unveil the genetics of testicular cancer

“Researchers develop the first in vitro seminoma model, shedding light on chromosomal anomalies and signaling pathways.” – Nathi Magubane for Penn Today

New Penn Medicine Nudge Unit pilots show how simple questions can lead to answers that improve care

Frank Otto for Penn Medicine News: “Through the work of Abike James, MD, MPH, an associate professor of Obstetrics and Gynecology, Penn Medicine has guidance in place to be more careful about … Continue reading New Penn Medicine Nudge Unit pilots show how simple questions can lead to answers that improve care